These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26628435)

  • 61. Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy.
    Berthelot C; Morel O; Girault S; Verrièle V; Poirier AL; Moroch J; Boucher Y; Le Jeune JJ; Lorimier G
    Nucl Med Commun; 2011 Jan; 32(1):23-9. PubMed ID: 21042225
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival.
    Avesani G; Arshad M; Lu H; Fotopoulou C; Cannone F; Melotti R; Aboagye E; Rockall A
    Radiol Med; 2020 Aug; 125(8):770-776. PubMed ID: 32239470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?
    Yan TD; Morris DL
    Ann Surg; 2008 Nov; 248(5):829-35. PubMed ID: 18948811
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.
    Gasimli K; Braicu EI; Richter R; Chekerov R; Sehouli J
    Ann Surg Oncol; 2015 Aug; 22(8):2729-37. PubMed ID: 25672560
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study.
    Leapman MS; Jibara G; Tabrizian P; Franssen B; Yang MJ; Romanoff A; Hall SJ; Palese M; Sarpel U; Hiotis S; Labow D
    Ann Surg Oncol; 2014 Apr; 21(4):1153-8. PubMed ID: 24322531
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
    Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Deraco M; Baratti D; Hutanu I; Bertuli R; Kusamura S
    Ann Surg Oncol; 2013 Apr; 20(4):1093-100. PubMed ID: 23456386
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systemic Chemotherapy using FLOT - Regimen Combined with Cytoreductive Surgery plus HIPEC for Treatment of Peritoneal Metastasized Gastric Cancer.
    Müller H; Hotopp T; Tofeili A; Wutke K
    Hepatogastroenterology; 2014 May; 61(131):703-6. PubMed ID: 26176060
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.
    Dineen SP; Royal RE; Hughes MS; Sagebiel T; Bhosale P; Overman M; Matamoros A; Mansfield PF; Fournier KF
    Ann Surg Oncol; 2015 Oct; 22(11):3640-6. PubMed ID: 25698402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Huge pseudomyxoma peritonei: Surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery.
    Benhaim L; Honoré C; Goéré D; Delhorme JB; Elias D
    Eur J Surg Oncol; 2016 Apr; 42(4):552-7. PubMed ID: 26868165
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
    Yonemura Y; Endou Y; Shinbo M; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Mizuno M; Miura M; Ikeda M; Ikeda S; Nakajima G; Yonemura J; Yuuba T; Masuda S; Kimura H; Matsuki N
    J Surg Oncol; 2009 Sep; 100(4):311-6. PubMed ID: 19697437
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    de Bree E; Koops W; Kröger R; van Ruth S; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2006 Feb; 32(1):65-71. PubMed ID: 16290055
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.
    Passot G; Vaudoyer D; Cotte E; You B; Isaac S; Noël Gilly F; Mohamed F; Glehen O
    Ann Surg; 2012 Jul; 256(1):125-9. PubMed ID: 22580942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).
    Milovanov V; Sardi A; Ledakis P; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
    Eur J Surg Oncol; 2015 May; 41(5):707-12. PubMed ID: 25633641
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection of peritoneal carcinomatosis by EUS fine-needle aspiration: impact on staging and resectability (with videos).
    Levy MJ; Abu Dayyeh BK; Fujii LL; Clayton AC; Reynolds JP; Lopes TL; Rao AS; Clain JE; Gleeson FC; Iyer PG; Kendrick ML; Rajan E; Topazian MD; Wang KK; Wiersema MJ; Chari ST
    Gastrointest Endosc; 2015 May; 81(5):1215-24. PubMed ID: 25660979
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience.
    Nikolic S; Dzodic R; Zegarac M; Djurisic I; Gavrilovic D; Vojinovic V; Kocic M; Santrac N; Radlovic P; Radosavljevic D; Pupic G; Martinovic A
    J BUON; 2014; 19(1):66-74. PubMed ID: 24659645
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and HIPEC: preliminary results in highly selected patients.
    Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2013 Dec; 68(6):551-8. PubMed ID: 24193287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.